Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial

DOI Full Paper Access

161

Citations

13

References

2019

Year

Florian von Groote-Bidlingmaier, R. F. Patientia, Epifanio Sánchez, Vincent M. Balanag, Eduardo Ticona, Patricia Segura, Elizabeth Cadena, Charles Yu, Andra Cīrule, Victor Lizarbe,

The Lancet Respiratory Medicine

Abstract

Otsuka Pharmaceutical.

References

	Year	Citations

Page 1